Interim Condensed Consolidated Statements of Income (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015
Revenues:
Net patient revenues	$ 216,487,000	$ 214,433,000	$ 434,593,000	$ 426,494,000
Other revenues	11,281,000	10,469,000	22,763,000	20,815,000
Net operating revenues	227,768,000	224,902,000	457,356,000	447,309,000
Cost and Expenses:
Salaries, wages and benefits	135,068,000	131,914,000	265,088,000	257,630,000
Other operating	57,306,000	57,467,000	118,615,000	117,214,000
Facility rent	10,319,000	9,981,000	20,646,000	19,966,000
Depreciation and amortization	9,495,000	9,236,000	18,849,000	18,169,000
Interest	939,000	598,000	1,893,000	1,188,000
Total costs and expenses	213,127,000	209,196,000	425,091,000	414,167,000
Income Before Non–Operating Income	14,641,000	15,706,000	32,265,000	33,142,000
Non–Operating Income	4,925,000	4,130,000	9,698,000	8,352,000
Income Before Income Taxes	19,566,000	19,836,000	41,963,000	41,494,000
Income Tax Provision	(7,700,000)	(7,478,000)	(16,398,000)	(15,894,000)
Net Income	11,866,000	12,358,000	25,565,000	25,600,000
Dividends to Preferred Stockholders		(2,167,000)		(4,335,000)
Net Income Available to Common Stockholders	$ 11,866,000	$ 10,191,000	$ 25,565,000	$ 21,265,000
Earnings Per Common Share:
Basic (in dollars per share)	$ 0.78	$ 0.74	$ 1.69	$ 1.54
Diluted (in dollars per share)	$ 0.78	$ 0.71	$ 1.68	$ 1.48
Weighted Average Common Shares Outstanding:
Basic (in shares)	15,266,559	13,772,873	15,091,732	13,767,248
Diluted (in shares)	15,289,104	14,381,746	15,212,275	14,336,027
Dividends declared to common stockholders per share (in dollars per share)	$ 0.45	$ 0.40	$ 0.85	$ 0.74